Treatment with Activated Protein C (aPC) Is Protective during the Development of Myocardial Fibrosis: An Angiotensin II Infusion Model in Mice

Mryanda J. Sopel, Nicole L. Rosin, Alec G. Falkenham, Michael Bezuhly, Charles T. Esmon, Timothy D.G. Lee, Robert S. Liwski, Jean Francois Légaré

Research output: Contribution to journalArticlepeer-review

13 Citations (Scopus)
Original languageEnglish
Article numbere45663
JournalPLoS ONE
Volume7
Issue number9
DOIs
Publication statusPublished - Sept 19 2012

ASJC Scopus Subject Areas

  • General Biochemistry,Genetics and Molecular Biology
  • General Agricultural and Biological Sciences
  • General

Fingerprint

Dive into the research topics of 'Treatment with Activated Protein C (aPC) Is Protective during the Development of Myocardial Fibrosis: An Angiotensin II Infusion Model in Mice'. Together they form a unique fingerprint.

Cite this

Sopel, M. J., Rosin, N. L., Falkenham, A. G., Bezuhly, M., Esmon, C. T., Lee, T. D. G., Liwski, R. S., & Légaré, J. F. (2012). Treatment with Activated Protein C (aPC) Is Protective during the Development of Myocardial Fibrosis: An Angiotensin II Infusion Model in Mice. PLoS ONE, 7(9), Article e45663. https://doi.org/10.1371/journal.pone.0045663